New partnership between Analis and GeneMind for Next-Generation Sequencing (NGS) in the Benelux
Analis announces an exciting new collaboration with GeneMind Biosciences Co., Ltd. for the Benelux market.
GeneMind Biosciences is a rapidly growing, global manufacturer of Next-Generation Sequencing (NGS) solutions, offering a complete sequencing ecosystem including scalable sequencing platforms, automation-friendly workflows, reagents, consumables, and integrated bioinformatics pipelines.
This new partnership further expands Analis' portfolio and enables seamless integration and complete workflows: from nucleic acid extraction and library preparation to sequencing, bioinformatics analysis, and reporting, all supported by a single, trusted partner.
GeneMind: one platform, one provider for end-to-end NGS sequencing without compromises
Applications:
- Oncology and precision medicine
- Whole-genome and whole-exome sequencing (WGS & WES)
- Infectious diseases and microbiology
- Single-cell and spatial transcriptomics
- Reproductive health and NIPT
- and more ……. CLICK HERE
More information – see our website.
Nederlands